The latest price target for Banco Macro (NYSE:BMA) was reported by Morgan Stanley on December 16, 2024. The analyst firm set a price target for $12.50 expecting BMA to fall to within 12 months (a possible -86.87% downside). 3 analyst firms have reported ratings in the last year.

The latest analyst rating for Banco Macro (NYSE:BMA) was provided by Morgan Stanley, and Banco Macro upgraded their overweight rating.

The last upgrade for Banco Macro SA happened on December 16, 2024 when Morgan Stanley raised their price target to $12.5. Morgan Stanley previously had an underweight for Banco Macro SA.

The last downgrade for Banco Macro SA happened on January 31, 2022 when JP Morgan changed their price target from $15 to $12 for Banco Macro SA.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Banco Macro, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Banco Macro was filed on December 16, 2024 so you should expect the next rating to be made available sometime around December 16, 2025.

While ratings are subjective and will change, the latest Banco Macro (BMA) rating was a upgraded with a price target of $0.00 to $12.50. The current price Banco Macro (BMA) is trading at is $95.21, which is out of the analyst’s predicted range.